Sahajanand Medical Technologies Limited
NSE: SMT · Medical Equipment & Supplies
Snapshot
Unlock Sahajanand Medical Technologies Limited's vital signs
Growth · Profitability · Valuation · Strength · Conviction
Company Overview
Business
Sahajanand Medical Technologies Limited is an R&D-driven medical devices company specializing in Class III and Class C/D devices for vascular and structural heart interventions. The company designs, manufactures, and markets a diverse product portfolio including coronary stents, balloons, transcatheter aortic valve implantation systems, and occluders across 77 countries.
Vertical mix
- NaN%
Business Model
The company generates revenue by manufacturing and marketing cardiovascular medical devices through direct, hybrid, and distributor-led sales models across global markets. Production is supported by three manufacturing facilities located in India and Thailand alongside two research and development centres.
- Total Revenue from Operations (Fiscal 2026):12,105.04 million rupees
- India DES Market Share (Volume, Fiscal 2026):Nearly 25%
Management Commentary
Management highlights the company's strong market positioning, holding a leading sales volume share in India for drug-eluting stents and ranking among the top five in several European and Latin American countries.
Growth Outlook
Growth is driven by expansion in global markets spanning 77 countries and continued demand for advanced vascular and structural heart intervention products. The company leverages its robust R&D capabilities to scale its footprint across international and domestic segments.
- Global Reach:77 countries
Key Risks
- Regulatory and Compliance Risks. Strict regulatory approvals required for Class III medical devices across multiple jurisdictions could delay product launches.
- Geographic Concentration. A significant portion of market share is concentrated in specific regions like India, exposing the company to local pricing pressures and regulatory changes.
- Intense Competition. The cardiovascular medical devices sector faces intense competition from global medtech players, potentially impacting pricing and margins.
Start your research today
Unlock AI insights, financials, peers and live data on Sahajanand Medical Technologies Limited and 5,000+ companies — free.
Peers · Medical Equipment & Supplies
| Company | Mkt Cap | P/E (TTM) | EV/EBITDA | Rev Gr YoY | EBITDA Mgn | ROE | ROCE | 1Y Return |
|---|---|---|---|---|---|---|---|---|
Sahajanand Medical Technologies LimitedSMT | ₹3,839 Cr | — | — | — | 14.0% | — | — | — |
Fischer Medical Ventures LimitedFISCHER | ₹1,628 Cr | 10.4× | 29.94 | 196.0% | 15.4% | 7.7% | 12.8% | -76.1% |
Tarsons ProductsTARSONS | ₹1,596 Cr | 143.5× | 13.39 | 10.6% | 33.1% | 1.8% | 4.5% | +3.4% |
Laxmi DentalLAXMIDENTL | ₹937 Cr | 30.1× | 16.89 | — | 19.2% | 13.7% | 13.3% | -45.1% |
Hemant Surgical Industries LimitedHSIL | ₹829 Cr | — | — | — | 10.0% | — | — | +100.5% |
Vasa Denticity LimitedDENTALKART | ₹794 Cr | — | — | — | 4.2% | — | — | -24.5% |
As of Mar 2026
Financials
Sahajanand Medical Technologies Limited
NSE: SMT · Medical Equipment & Supplies
Snapshot
Unlock Sahajanand Medical Technologies Limited's vital signs
Growth · Profitability · Valuation · Strength · Conviction
Company Overview
Business
Sahajanand Medical Technologies Limited is an R&D-driven medical devices company specializing in Class III and Class C/D devices for vascular and structural heart interventions. The company designs, manufactures, and markets a diverse product portfolio including coronary stents, balloons, transcatheter aortic valve implantation systems, and occluders across 77 countries.
Vertical mix
- NaN%
Business Model
The company generates revenue by manufacturing and marketing cardiovascular medical devices through direct, hybrid, and distributor-led sales models across global markets. Production is supported by three manufacturing facilities located in India and Thailand alongside two research and development centres.
- Total Revenue from Operations (Fiscal 2026):12,105.04 million rupees
- India DES Market Share (Volume, Fiscal 2026):Nearly 25%
Management Commentary
Management highlights the company's strong market positioning, holding a leading sales volume share in India for drug-eluting stents and ranking among the top five in several European and Latin American countries.
Growth Outlook
Growth is driven by expansion in global markets spanning 77 countries and continued demand for advanced vascular and structural heart intervention products. The company leverages its robust R&D capabilities to scale its footprint across international and domestic segments.
- Global Reach:77 countries
Key Risks
- Regulatory and Compliance Risks. Strict regulatory approvals required for Class III medical devices across multiple jurisdictions could delay product launches.
- Geographic Concentration. A significant portion of market share is concentrated in specific regions like India, exposing the company to local pricing pressures and regulatory changes.
- Intense Competition. The cardiovascular medical devices sector faces intense competition from global medtech players, potentially impacting pricing and margins.
Start your research today
Unlock AI insights, financials, peers and live data on Sahajanand Medical Technologies Limited and 5,000+ companies — free.
Peers · Medical Equipment & Supplies
As of Mar 2026